UNSPSC 51351620: Estradiol benzoate

This classification denotes a therapeutic estradiol with the molecular formula C25H28O3, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 1S4CJB5ZGN, chemically known as estra-1,3,5(10)-triene-3,17-diol (17.beta.)-, 3-benzoate but more generally known as estradiol benzoate, which bears US NIH Compound Identifier 3262. European Medicines Agency schedules Estradiol benzoate in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB07243MIG. The term ESTRADIOL BENZOATE is an International Non-Proprietary Name.

UNSPSC 51351620 Estradiol benzoate is a Commodity code tracking individual pharmaceutical active ingredients and finished-dose products. State and local governments procure under this code as part of broader multi-source generic pharmaceutical contracts that supply hospitals, clinics, correctional facilities, and other public health and human-services entities. The Minnesota Multistate Cooperative Purchasing Alliance (MMCAP), administered by the Minnesota Department of Administration's Office of State Procurement, represents the primary issuing body active in this space, leveraging cooperative purchasing mechanisms to aggregate demand across multiple states and local jurisdictions. Procurement under the code typically requires manufacturers to supply products through designated pharmaceutical wholesalers with cGMP and Drug Supply Chain Security Act (DSCSA) compliance, maintain specified insurance coverage including commercial general liability and network security liability, and offer flexible pricing structures such as flat price, net price formats, or WAC-minus discounting. Vendors must also demonstrate EDI capability and comply with FDA requirements including minimum shelf-life standards.

MMCAP's January 2026 Request for Proposal for Generic Multi Source Pharmaceuticals and OTC Products, due March 26, 2026, represents the most recent documented activity under this code. The procurement establishes multiple contracts for distribution across participating state and local government facilities in Minnesota, Oregon, and other MMCAP member jurisdictions, with awarded vendors effective July 1, 2026. Pricing is weighted at 75 percent of the evaluation, with administrative compliance, EDI capability, and pricing format agreement each accounting for 5 percent, and fixed pricing for 10 percent. The contract term runs two years for new respondents with optional extensions, while incumbents' amendments align with existing expiration dates through June 30, 2028. No specific set-aside designations or budget ceiling is disclosed in the RFP.